LinKinVax’s universal vaccines platform is the work of the Vaccine Research Institute (VRI), created by Pr. Yves Lévy in 2011.
For ten years, the VRI, under the umbrella of INSERM and University Paris Est Créteil, has been leading 40 projects involving 150 researchers from 20 academic and industrial partners building a transdisciplinary approach from the basic sciences in the field of immunological, virological and translational research into the development of a clinical therapeutic and prophylactic program.